The surviving EGFR-low cells attract fibroblasts, secrete immunosuppressive cytokines, and actively contribute to the formation of the drug resistant niche, finally enabling the regrowth of the tumor cells (Fig. 5L). Here, EGFR is linked to neoplasm.